Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome
<b>Background/Objectives</b>: Early diagnosis and oral or, in severe cases, intravenous antibiotics are usually effective for Lyme disease, but some patients have persistent symptoms unresponsive to standards of care, requiring alternative therapies. Disulfiram (DIS), a drug for alcoholi...
Saved in:
| Main Authors: | Beáta-Mária Benkő, Bálint-Imre Szabó, Szabina Kádár, Edina Szabó, Gergő Tóth, Lajos Szente, Péter Tonka-Nagy, Romána Zelkó, István Sebe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/7/849 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aspects of the Immunopathogenesis of Lyme Arthritis
by: Leonard H. Sigal
Published: (2025-07-01) -
Current Strategies for Vaccine Prophylaxis of Lyme Disease
by: N. M. Kolyasnikova, et al.
Published: (2024-05-01) -
Structure of inclusion complex of disulfiram with hydroxypropyl-β-cyclodextrin
by: V. S. Tyukova, et al.
Published: (2015-10-01) -
Immunotropic effects of Curcuma longa extract as a component of original rectal suppositories in the dynamics of experimental Сrohn’s disease
by: М. V. Osikov, et al.
Published: (2020-05-01) -
STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES
by: S. A. Kedik, et al.
Published: (2019-01-01)